Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Stroke | Research

Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke

Authors: Qun Gao, Peng Qi, Junjie Wang, Shen Hu, Ximeng Yang, Jingwen Fan, Ling Li, Yao Lu, Jun Lu, Juan Chen, Daming Wang

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Type 2 diabetes mellitus (T2DM) affects the occurrence and prognosis of acute ischemic stroke (AIS). However, the impact of diabetes on thrombus characteristics is unclear. The relationship between the composition and ultrastructure of clots and DM with admission hyperglycemia was investigated.

Methods

Consecutive patients with AIS who underwent endovascular thrombus retrieval between June 2017 and May 2021 were recruited. The thrombus composition and ultrastructure were evaluated using Martius scarlet blue stain and scanning electron microscopy. Clot perviousness was evaluated via thrombus attenuation increase on computed tomography angiography (CTA) versus non-contrast CT. Patients with admission hyperglycemia DM (ahDM) and those without DM (nonDM) were compared in terms of thrombus composition, ultrastructure, and perviousness.

Results

On admission, higher NIHSS scores (17 vs. 12, respectively, p = 0.015) was evident in ahDM patients. After the 90-day follow-up, the rates of excellent outcomes (mRS 0–1) were lower in patients with ahDM (16.6%, p = 0.038), but functional independence (mRS 0–2) and handicapped (mRS 3–5) were comparable between patients with ahDM and nonDM. The outcome of mortality was higher in patients with ahDM (33.3%, p = 0.046) than in nonDM patients. Clots in patients with ahDM had more fibrin (39.4% vs. 25.0%, respectively, p = 0.007), fewer erythrocyte components (21.2% vs. 41.5%, respectively, p = 0.043), equivalent platelet fraction (27.7% vs. 24.6%, respectively, p = 0.587), and higher WBC counts (4.6% vs. 3.3%, respectively, p = 0.004) than in nonDM patients. The percentage of polyhedral erythrocytes in thrombi was significantly higher in ahDM patients than in nonDM patients (68.9% vs. 45.6%, respectively, p = 0.007). The proportion of pervious clots was higher in patients nonDM than in patients with ahDM (82.61% vs. 40%, respectively, p = 0.026).

Conclusion

Patients with ahDM presented with greater stroke severity on admission and poorer functional outcomes after 3 months. Clots in patients with ahDM had more fibrin, leucocytes, and fewer erythrocyte components than in patients nonDM. The content of polyhedral erythrocytes and impervious clots proportion were significantly higher in thrombi of patients with AIS and ahDM. Further research is required to validate these findings.
Literature
1.
Mozaffarian D, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.PubMed
2.
Luitse MJ, et al. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11(3):261–71.PubMedCrossRef
3.
4.
Gray CS, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007;6(5):397–406.PubMedCrossRef
5.
Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007;27(3):435–51.PubMedCrossRef
6.
Kosiborod M. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Endocrinol Metab Clin N Am. 2018;47(1):185–202.CrossRef
7.
Lemkes BA, et al. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–9.CrossRef
8.
Sporns PB, et al. Ischemic stroke: what does the histological composition tell us about the origin of the thrombus? Stroke. 2017;48(8):2206–10.PubMedCrossRef
9.
Simons N, et al. Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval. J Neuroradiol. 2015;42(2):86–92.PubMedCrossRef
10.
Choi MH, et al. Erythrocyte fraction within retrieved thrombi contributes to thrombolytic response in acute ischemic stroke. Stroke. 2018;49(3):652–9.PubMedCrossRef
11.
Lam WA, et al. Mechanics and contraction dynamics of single platelets and implications for clot stiffening. Nat Mater. 2011;10(1):61–6.PubMedCrossRef
12.
Cines DB, et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood. 2014;123(10):1596–603.PubMedPubMedCentralCrossRef
13.
Tutwiler V, et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Blood. 2016;127(1):149–59.PubMedPubMedCentralCrossRef
14.
Carr ME, Krishnaswami A, Martin EJ. Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain. Diabet Med. 2002;19(10):862–6.PubMedCrossRef
15.
Gresele P, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003;41(6):1013–20.PubMedCrossRef
16.
Ye G, et al. The role of diabetes mellitus on the thrombus composition in patients with acute ischemic stroke. Interv Neuroradiol. 2020;26(3):329–36.PubMedPubMedCentralCrossRef
17.
Erratum. Classification and diagnosis of diabetes. Sec. 2, et al. Diabetes Care. 2016;39(9):1653.CrossRef
18.
Khismatullin RR, et al. Quantitative morphology of cerebral thrombi related to Intravital contraction and clinical features of ischemic stroke. Stroke. 2020;51(12):3640–50.PubMedCrossRef
19.
Adams HP Jr, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.PubMedCrossRef
20.
Zaidat OO, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650–63.PubMedPubMedCentralCrossRef
21.
22.
23.
Jørgensen H, et al. Stroke in patients with diabetes. The Copenhagen stroke study. Stroke. 1994;25(10):1977–84.PubMedCrossRef
24.
Karapanayiotides T, et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62(9):1558–62.PubMedCrossRef
25.
Tuttolomondo A, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis. 2008;18(2):152–7.PubMedCrossRef
26.
Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes. 1989;38(3):350–7.PubMedCrossRef
27.
MacDougall NJ, Muir KW. Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(3):807–18.PubMedCrossRef
28.
29.
Ajjan RA, et al. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity. Blood. 2013;122(1):134–42.PubMedCrossRef
30.
31.
32.
Undas A, et al. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31(8):1590–5.PubMedPubMedCentralCrossRef
33.
Przygodzki T, et al. Diabetes and hyperglycemia affect platelet GPIIIa expression. Effects on adhesion potential of blood platelets from diabetic patients under in vitro flow conditions. Int J Mol Sci. 2020;21(9):3222.
34.
Winocour PD. Platelets, vascular disease, and diabetes mellitus. Can J Physiol Pharmacol. 1994;72(3):295–303.PubMedCrossRef
35.
Elalamy I, et al. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res. 2008;121(6):843–8.PubMedCrossRef
36.
Singh P, Kaur R, Kaur A. Clot composition and treatment approach to acute ischemic stroke: the road so far. Ann Indian Acad Neurol. 2013;16(4):494–7.PubMedPubMedCentralCrossRef
37.
Gunning GM, et al. Clot friction variation with fibrin content; implications for resistance to thrombectomy. J Neurointerv Surg. 2018;10(1):34–8.PubMedCrossRef
38.
Tutwiler V, et al. Pathologically stiff erythrocytes impede contraction of blood clots. J Thromb Haemost. 2021;19(8):1990–2001.PubMedCrossRef
39.
40.
Mokin M, et al. Clot perviousness is associated with first pass success of aspiration thrombectomy in the COMPASS trial. J Neurointerv Surg. 2021;13(6):509–14.PubMedCrossRef
41.
Benson JC, et al. Clot permeability and histopathology: is a clot's perviousness on CT imaging correlated with its histologic composition? J Neurointerv Surg. 2020;12(1):38–42.PubMedCrossRef
42.
Muthard RW, Diamond SL. Blood clots are rapidly assembled hemodynamic sensors: flow arrest triggers intraluminal thrombus contraction. Arterioscler Thromb Vasc Biol. 2012;32(12):2938–45.PubMedPubMedCentralCrossRef
43.
Santos EM, et al. Thrombus permeability is associated with improved functional outcome and recanalization in patients with ischemic stroke. Stroke. 2016;47(3):732–41.PubMedCrossRef
Metadata
Title
Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke
Authors
Qun Gao
Peng Qi
Junjie Wang
Shen Hu
Ximeng Yang
Jingwen Fan
Ling Li
Yao Lu
Jun Lu
Juan Chen
Daming Wang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02660-y

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue

Research

Mechanical thrombectomy in acute basilar artery stroke: a systematic review and Meta-analysis of randomized controlled trials

Research

Peak expiratory flow is a reliably household pulmonary function parameter correlates with disease severity and survival of patients with amyotrophic lateral sclerosis

Research article

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries

Research

Cognitive function is associated with home discharge in subacute stroke patients: a retrospective cohort study

Case report

Neuromyelitis optica spectrum disease coexisting with subacute combined degeneration: a case report

Case report

Progressive sensory ataxia and breast implant rupture, an uncommon presentation of a debated concept: a case report